Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

471
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
471
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

37
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving readability of layperson abstracts and summaries in oncology using task-specific large language model powered tool: results from the BRIDGE-AI 7 study.

JAMIA open·2026
Same author

Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy.

BJU international·2026
Same author

Acute deep vein thrombosis: who still needs hospital admission?

QJM : monthly journal of the Association of Physicians·2026
Same author

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

Theranostics·2026
Same author

Comparative Effectiveness and Cost-Effectiveness of an Artificial Intelligence Workflow for Small Renal Mass Diagnosis on Computed Tomography.

Urology practice·2026
Same author

Development and validation of PEYRO-Q: a novel multidimensional patient-reported outcome measure for Peyronie's disease.

Sexual medicine·2026

Related Experiment Video

Updated: May 21, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

474

Large language models for automating clinical trial matching.

Ethan Layne1,2, Claire Olivas1,2, Jacob Hershenhouse1,2

  • 1USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine.

Current Opinion in Urology
|March 21, 2025
PubMed
Summary
This summary is machine-generated.

Generative artificial intelligence (GAI) using large language models (LLMs) shows promise for matching patients to cancer clinical trials. While effective with artificial data, human oversight is crucial for real-world application and patient safety.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: May 21, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

474
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Oncology
  • Clinical Trial Management

Background:

  • Generative artificial intelligence (GAI) and large language models (LLMs) are increasingly utilized in medicine.
  • Patient matching to clinical trials is a critical area for GAI/LLM application.
  • This review focuses on the current capabilities of LLMs in clinical trial matching.

Purpose of the Study:

  • To provide an overview of the current state of leveraging LLMs for clinical trial matching.
  • To assess the performance of LLMs in matching patients to oncologic clinical trials.

Main Methods:

  • Review of recent studies on LLM performance in clinical trial matching.
  • Examination of LLM application in matching patient health records to trial eligibility criteria.

Main Results:

  • LLMs demonstrate promising results in matching patients to oncologic clinical trials, particularly with artificial datasets.
  • Current LLM systems require human oversight for accurate and safe application.
  • Studies indicate potential benefits like improved patient access and reduced provider workload.

Conclusions:

  • Automated clinical trial matching via LLMs can enhance patient access, autonomy, and trial enrollment.
  • Challenges include potential "false hope" for patients, navigation difficulties, and the need for human oversight.
  • Further research is essential to ensure the safety and efficacy of LLM-based matching in oncology, addressing data privacy and EMR/EHR integration.